Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q4 2025 Earnings

12NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.47

-0.4

-0.33

-0.26

Details

Expected EPS

-0.37

Actual EPS

-0.26

Surprise EPS

0.11

Surprise Percent

+29.73%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.26 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.